[1]Niansong,Qian,Nobuko,等.Breast cancer stemlike cells and breast cancer therapy[J].中华乳腺病杂志(电子版),2010,4(5):530-543.
点击复制
Breast cancer stemlike cells and breast cancer therapy()
中华乳腺病杂志(电子版)[ISSN:1674-0807/CN:11-9146/R]
- 卷:
-
第4卷
- 期数:
-
2010年5期
- 页码:
-
530-543
- 栏目:
-
综述
- 出版日期:
-
2010-10-01
文章信息/Info
- 作者:
-
Niansong;Qian;Nobuko;Kawaguchi-Sakita;Masakazu;Toi
-
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 shogoin-kawahara cho, sakyoku, Kyoto 606-8501, Japan.
- 关键词:
-
Breast cancer stem cells; Signaling pathway; Resistance
- 摘要:
-
Until the early 1990s, human cancers were considered a morphologically heterogeneous population of cells. In 1997, Bonnet et al demonstrated that a small population of leukemia cells was able to differentiate in vivo into leukemic blasts, indicating that the leukemic clone was organized as a hierarchy; this was subsequently denoted as cancer stemlike cells (CSCs). CSCs are cancer cells that possess characteristics associated with normal stem cells and have the specific ability to give rise to all cell types found in a particular cancer. One reason for the failure of traditional antitumor therapies might be their inability to eradicate CSCs. Therefore, therapies must identify and destroy CSCs in both primary and metastatic tumors.
更新日期/Last Update:
2010-01-20